Jiménez-Vicente C, Arribas I, Pomares H, Ramil G, Castaño-Diez S, Pérez-Valencia AI, Sturla AL, López-Guerra M, Martinez-Roca A, Zugasti I, Guijarro F, Cortés-Bullich A, Merchán B, Triguero A, Monge I, Tuca A, Oñate G, Garrido A, Sierra J, Arnan M, Esteve J, Díaz-Beyá M, Group SC. Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia. haematol [Internet]. 2020Sep.10 [cited 2025Feb.1];. Available from: https://haematologica.org/article/view/11910